• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Bentyl (dicyclomine hydrochloride, USP) Capsules/Tablets, Oral Syrup, Injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2011

 

Summary View

5 WARNINGS AND PRECAUTIONS

5.1 Inadvertent Intravenous Administration
  • BENTYL solution is for intramuscular administration only. Do not administer by any other route. Inadvertent intravenous administration may result in thrombosis, thrombophlebitis, and injection site reactions such as pain, edema, skin color change, and reflux sympathetic dystrophy syndrome [see Adverse Reactions (6.2)].